Viska Bio
UEI: DHV3ZLYRD1D5
• CAGE: 9LPD3
Overview
Awardee Type
Parent
Federal Capability Statement
VISKA BIO, INC. is a pioneering biotechnology company based in Cambridge, Massachusetts, specializing in the development of cutting-edge immunotherapies targeting cancer. The company's innovative approach leverages the body's innate immune system to combat both chronic and infectious diseases, with a particular focus on cancer therapies for tumors resistant to conventional treatments (termed cold tumors).
Keywords
Biotechnology Research, Experimental Development in Biotechnology, Biotech Solutions, Life Sciences Research, Biopharmaceutical Development, Genetic Engineering, Biotech Innovation, Research and Development (R&D), Molecular Biology, Biomedical Research, Biotech Applications, Biosciences, Biotechnology R&D, Applied Research in Biotechnology, Biotechnology Basic Research, Scientific Data Analysis, Biotechnology Engineering, Biomedical Engineering, Biotech Consulting, Government R&D Contracts
Headquarters
Cambridge, MA
United States
United States
Federal recipient
VISKA BIO, INC.
(UEI DHV3ZLYRD1D5, CAGE 9LPD3)
is headquartered in Cambridge MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2021 and
federally registered in
May 2023.
Federal Registration and Certifications
Legal Name
VISKA BIO, INC.
UEI
DHV3ZLYRD1D5
CAGE Code
9LPD3
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 23, 2021
Initial Registration
May 30, 2023
Last Registration
Sept. 26, 2024
Registration Activation
Sept. 26, 2024
Registration Expiration
Sept. 24, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MA
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported PSC
Accepts Credit Cards
No